Author:
Batra Ullas,Sharma Mansi,Nathany Shrinidhi,Soni Satyajeet,Bansal Abhishek,Jain Parveen,Mehta Anurag
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular analysis for EGFR, ALK, and ROS1 alterations in over 3000 Indian patients with non-small-cell lung cancer: A retrospective observational study;Cancer Research, Statistics, and Treatment;2024-01
2. Selpercatinib: A narrative drug review;Cancer Research, Statistics, and Treatment;2024-01
3. The mighty minions of non-small-cell lung cancer: EGFR, ALK, and ROS1;Cancer Research, Statistics, and Treatment;2024-01
4. Testing modalities for ALK-driven lung cancer: A narrative review;Cancer Research, Statistics, and Treatment;2023
5. Amivantamab: Is it really a game changer for EGFR exon 20 insertion mutation?;Cancer Research, Statistics, and Treatment;2023